Literature DB >> 30770715

Comorbidities (excluding lymphoma) in Sjögren's syndrome.

José M Pego-Reigosa1, Juliana Restrepo Vélez1, Chiara Baldini2, Íñigo Rúa-Figueroa Fernández de Larrinoa3.   

Abstract

The information about comorbidities (excluding lymphoma) in primary Sjögren's syndrome (pSS) is relatively scarce. Cardiovascular disease, infections, musculoskeletal conditions or malignancy are likely the most relevant comorbid conditions in pSS. Different infections (particularly oral candidal infections) and fibromyalgia are extremely frequent in the daily clinical practice. On the other hand, the incidence of cardiovascular events and cancer in pSS is low, so information about them comes from large epidemiological studies or meta-analysis. For this reason, preclinical vascular disease is investigated by different techniques, demonstrating the presence of early atherosclerosis in pSS patients. Coronary events could be slightly more frequent in pSS than in the general population. The overall risk of malignancy in pSS patients seems to be slightly increased, likely due to excess occurrence of lymphoma. An association between pSS and thyroid cancer might exist, although it should be confirmed by further investigations.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  atherosclerosis; cancer; cardiovascular events; comorbidity; fibromyalgia; infection; malignancy; oral infection; primary Sjögren’s syndrome

Mesh:

Year:  2021        PMID: 30770715     DOI: 10.1093/rheumatology/key329

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

1.  Association between a History of herpes zoster and the risk of Sjögren's syndrome: a nationwide, population-based, case-control study.

Authors:  Pei Ju Huang; Shih-Ping Lin; Chun-Yi Wu; Yen-Tze Liu; Hsin-Hua Chen
Journal:  BMJ Open       Date:  2022-10-14       Impact factor: 3.006

2.  Comorbidities in the UK Primary Sjögren's Syndrome Registry.

Authors:  Jessica Tarn; Dennis Lendrem; Michael Barnes; John Casement; Wan-Fai Ng
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

3.  Disseminated histoplasmosis in primary Sjögren syndrome: A case report.

Authors:  Jia-Ai Li; Ying-Ying Cheng; Zhi-Tao Cui; Wei Jiang; Wu-Qiong Zhang; Zhong-Hua Du; Bin Gao; Yin-Yin Xie; Hong-Mei Meng
Journal:  World J Clin Cases       Date:  2020-04-06       Impact factor: 1.337

4.  Hospitalization Risks for Neurological Disorders in Primary Sjögren's Syndrome Patients.

Authors:  Radjiv Goulabchand; Audrey Gabelle; Xavier Ayrignac; Nicolas Malafaye; Pierre Labauge; Danièle Noël; Jacques Morel; Camille Roubille; Lucie Barateau; Philippe Guilpain; Thibault Mura
Journal:  J Clin Med       Date:  2022-04-01       Impact factor: 4.241

5.  Higher Risk for Sjögren's Syndrome in Patients With Fibromyalgia: A Nationwide Population-Based Cohort Study.

Authors:  Shuo-Yan Gau; Pui-Ying Leong; Cheng-Li Lin; Hsi-Kai Tsou; James Cheng-Chung Wei
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

6.  Transcriptomic and Single-Cell Analysis Reveals Regulatory Networks and Cellular Heterogeneity in Mouse Primary Sjögren's Syndrome Salivary Glands.

Authors:  Erich Horeth; Akinsola Oyelakin; Eun-Ah Christine Song; Monika Che; Jonathan Bard; Sangwon Min; Jeremy Kiripolsky; Jill M Kramer; Satrajit Sinha; Rose-Anne Romano
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 8.786

7.  Sex differences in comorbidities associated with Sjögren's disease.

Authors:  Katelyn A Bruno; Andrea Carolina Morales-Lara; Edsel B Bittencourt; Habeeba Siddiqui; Gabriella Bommarito; Jenil Patel; John M Sousou; Gary R Salomon; Rinald Paloka; Shelby T Watford; David O Hodge; Scott M Lieberman; Todd D Rozen; Paldeep S Atwal; Peter T Dorsher; Lynsey A Seim; DeLisa Fairweather
Journal:  Front Med (Lausanne)       Date:  2022-08-04

8.  The interplay between cognition, depression, anxiety, and sleep in primary Sjogren's syndrome patients.

Authors:  Radjiv Goulabchand; Elodie Castille; Audrey Gabelle; Philippe Guilpain; Sophie Navucet; Damien Etchecopar-Etchart; Aurélie Matos; Alexandre Maria; Laure Anne Gutierrez; Alain Le Quellec; Nicolas Menjot de Champfleur
Journal:  Sci Rep       Date:  2022-08-01       Impact factor: 4.996

9.  P2Y2 receptor antagonism resolves sialadenitis and improves salivary flow in a Sjögren's syndrome mouse model.

Authors:  Kimberly J Jasmer; Lucas T Woods; Kevin Muñoz Forti; Adam L Martin; Jean M Camden; Marco Colonna; Gary A Weisman
Journal:  Arch Oral Biol       Date:  2021-02-03       Impact factor: 2.633

10.  Comment on: Comorbidities (excluding lymphoma) in Sjögren's syndrome. Reply.

Authors:  José M Pego-Reigosa; Íñigo Rúa-Figueroa Fernández de Larrinoa
Journal:  Rheumatology (Oxford)       Date:  2021-12-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.